Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Share-based Compensation (2023 - 2025)

Guardian Pharmacy Services' Share-based Compensation history spans 3 years, with the latest figure at $1.1 million for Q4 2025.

  • For Q4 2025, Share-based Compensation fell 68.8% year-over-year to $1.1 million; the TTM value through Dec 2025 reached $13.8 million, down 89.47%, while the annual FY2025 figure was $13.8 million, 89.47% down from the prior year.
  • Share-based Compensation for Q4 2025 was $1.1 million at Guardian Pharmacy Services, down from $4.4 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $122.4 million in Q3 2024 and bottomed at -$22.7 million in Q4 2023.
  • The 3-year median for Share-based Compensation is $4.0 million (2025), against an average of $13.6 million.
  • The largest YoY upside for Share-based Compensation was 1734.93% in 2025 against a maximum downside of 96.44% in 2025.
  • A 3-year view of Share-based Compensation shows it stood at -$22.7 million in 2023, then surged by 115.23% to $3.5 million in 2024, then plummeted by 68.8% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for GRDN's Share-based Compensation are $1.1 million (Q4 2025), $4.4 million (Q3 2025), and $4.4 million (Q2 2025).